191 related articles for article (PubMed ID: 32123072)
1. Cell-penetrating peptide inhibits retromer-mediated human papillomavirus trafficking during virus entry.
Zhang P; Moreno R; Lambert PF; DiMaio D
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6121-6128. PubMed ID: 32123072
[TBL] [Abstract][Full Text] [Related]
2. Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection.
Popa A; Zhang W; Harrison MS; Goodner K; Kazakov T; Goodwin EC; Lipovsky A; Burd CG; DiMaio D
PLoS Pathog; 2015 Feb; 11(2):e1004699. PubMed ID: 25693203
[TBL] [Abstract][Full Text] [Related]
3. Cell-Penetrating Peptide Mediates Intracellular Membrane Passage of Human Papillomavirus L2 Protein to Trigger Retrograde Trafficking.
Zhang P; Monteiro da Silva G; Deatherage C; Burd C; DiMaio D
Cell; 2018 Sep; 174(6):1465-1476.e13. PubMed ID: 30122350
[TBL] [Abstract][Full Text] [Related]
4. Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.
Yan H; Foo SS; Chen W; Yoo JS; Shin WJ; Wu C; Jung JU
mBio; 2019 Aug; 10(4):. PubMed ID: 31387913
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus 16 L2 Recruits both Retromer and Retriever Complexes during Retrograde Trafficking of the Viral Genome to the Cell Nucleus.
Pim D; Broniarczyk J; Siddiqa A; Massimi P; Banks L
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177206
[TBL] [Abstract][Full Text] [Related]
6. The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry.
Lipovsky A; Erden A; Kanaya E; Zhang W; Crite M; Bradfield C; MacMicking J; DiMaio D; Schoggins JW; Iwasaki A
J Gen Virol; 2017 Nov; 98(11):2821-2836. PubMed ID: 29058661
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus.
Lipovsky A; Popa A; Pimienta G; Wyler M; Bhan A; Kuruvilla L; Guie MA; Poffenberger AC; Nelson CD; Atwood WJ; DiMaio D
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7452-7. PubMed ID: 23569269
[TBL] [Abstract][Full Text] [Related]
9. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
Day PM; Thompson CD; Lowy DR; Schiller JT
J Virol; 2017 May; 91(10):. PubMed ID: 28250129
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.
Day PM; Weisberg AS; Thompson CD; Hughes MM; Pang YY; Lowy DR; Schiller JT
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092566
[TBL] [Abstract][Full Text] [Related]
11. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
Wiens ME; Smith JG
J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
[TBL] [Abstract][Full Text] [Related]
12. Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity.
Zhang W; Kazakov T; Popa A; DiMaio D
mBio; 2014 Sep; 5(5):e01777-14. PubMed ID: 25227470
[TBL] [Abstract][Full Text] [Related]
13. TBC1D5-Catalyzed Cycling of Rab7 Is Required for Retromer-Mediated Human Papillomavirus Trafficking during Virus Entry.
Xie J; Heim EN; Crite M; DiMaio D
Cell Rep; 2020 Jun; 31(10):107750. PubMed ID: 32521275
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects and mechanisms of polymannuroguluronate sulfate against human papillomavirus infection in vitro and in vivo.
Wang S; Lu Z; Wang S; Liu W; Gao J; Tian L; Wang L; Zhang X; Zhao X; Wang W; Li C
Carbohydr Polym; 2020 Aug; 241():116365. PubMed ID: 32507208
[TBL] [Abstract][Full Text] [Related]
15. A Novel PDZ Domain Interaction Mediates the Binding between Human Papillomavirus 16 L2 and Sorting Nexin 27 and Modulates Virion Trafficking.
Pim D; Broniarczyk J; Bergant M; Playford MP; Banks L
J Virol; 2015 Oct; 89(20):10145-55. PubMed ID: 26202251
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus L2 Capsid Protein Stabilizes γ-Secretase during Viral Infection.
Crite M; DiMaio D
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458534
[TBL] [Abstract][Full Text] [Related]
17. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
[TBL] [Abstract][Full Text] [Related]
18. Sequence-independent activity of a predicted long disordered segment of the human papillomavirus type 16 L2 capsid protein during virus entry.
Oh C; Buckley PM; Choi J; Hierro A; DiMaio D
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2307721120. PubMed ID: 37819982
[TBL] [Abstract][Full Text] [Related]
19. Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.
DiGiuseppe S; Keiffer TR; Bienkowska-Haba M; Luszczek W; Guion LG; Müller M; Sapp M
J Virol; 2015 Oct; 89(20):10442-52. PubMed ID: 26246568
[TBL] [Abstract][Full Text] [Related]
20. Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry.
Choi J; DiMaio D
PLoS Pathog; 2023 Sep; 19(9):e1011648. PubMed ID: 37703297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
